PROTEIN SYNTHESIS POST-TRANSLATION MODIFICATION AND DEGRADATION
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin: IMPLICATIONS FOR METABOLIC REGULATION AND BIOACTIVITY*

https://doi.org/10.1074/jbc.M207198200Get rights and content
Under a Creative Commons license
open access

Acrp30/adiponectin is an adipocyte-specific secretory protein that has recently been implicated as a mediator of systemic insulin sensitivity with liver and muscle as target organs. Acrp30 is found as two forms in serum, as a lower molecular weight trimer-dimer and a high molecular weight complex. Little is know about the regulation and significance of these Acrp30 complexes in serum and about the events that lead to the generation of the bioactive ligand. Here, we show that there is a profound sexual dimorphism of Acrp30 levels and complex distribution in serum. Female mice display significantly higher levels of the high molecular weight complex in serum than males. In both females and males, levels of the high molecular weight complex are significantly reduced in response to a systemic increase of insulin. The ratio of the two complexes is restored upon normalization of glucose levels. Structurally, we show that oligomer formation of Acrp30 critically depends on disulfide bond formation mediated by Cys-39. Mutation of Cys-39 results in trimers that are subject to proteolytic cleavage in the collagenous domain. Surprisingly, Acrp30(C39S) or wild-type Acrp30 treated with dithiothreitol are significantly more bioactive than the higher order oligomeric forms of the protein with respect to reduction of serum glucose levels. Furthermore, treatment of primary hepatocytes with trimeric and higher order forms of Acrp30 confirms that the increased bioactivity seen in vivo is reflected in an augmented potency to reduce glucose output in the presence of gluconeogenic stimuli. Combined, these results shed new light on the regulation of this complex protein and suggest a new model for in vivo activation of the protein, implicating a serum reductase activity.

Cited by (0)

Published, JBC Papers in Press, December 20, 2002, DOI 10.1074/jbc.M207198200

*

This work was supported in part by National Institutes of Health Medical Scientist Training Grant T32-GM07288 (to U. B. P. and M. W. R.), National Institutes of Health National Research Service Award DK61228 (to T. P. C.), an American Diabetes Medical Scientist Training grant (to A. H. B.), and National Institutes of Health Grant 1R01-DK55758 (to P. E. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.